Asenapine Maleate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Asenapine Maleate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Asenapine Maleate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 14 USDMF, 1 JDMF, 5 EU WC, 7 NDC API, 12 Listed Suppliers, $ API Reference Price

23 API Suppliers
14 USDMF
1 JDMF
5 EU WC
7 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

28 FDF Dossiers, 14 FDA Orange Book, 8 Europe, 2 Canada, 2 Australia, 2 Listed Dossiers

28 FDF Dossiers
14 FDA Orange Book
8 Europe
2 Canada
2 Australia
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;SUBLINGUAL - EQ 10MG BASE, TABLET;SUBLINGUAL - EQ 2.5MG BASE, TABLET;SUBLINGUAL - EQ 5MG BASE

TABLET;SUBLINGUAL - EQ 10MG BASE
TABLET;SUBLINGUAL - EQ 2.5MG BASE
TABLET;SUBLINGUAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 4 DKSH, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Pfanstiehl, 4 ACG Worldwide, 1 BASF, 1 Bioplus Life Sciences, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 2 Pluviaendo, 1 Qualicaps, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

2 Rochem International Inc
13 SPI Pharma
4 DKSH
1 Pharm-RX Chemical
2 Faran Shimi Pharmaceutical
2 Gangwal Healthcare
1 Pfanstiehl
4 ACG Worldwide
1 BASF
1 Bioplus Life Sciences
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
3 Lonza Capsugel
2 Microlex e.U
2 Pluviaendo
1 Qualicaps
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 10 Direct Compression, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Thickeners and Stabilizers, 5 Co-Processed Excipients, 4 Parenteral, 3 Granulation, 1 Solubilizers

21 Fillers, Diluents & Binders
12 Taste Masking
11 Chewable & Orodispersible Aids
10 Direct Compression
8 Empty Capsules
7 Disintegrants & Superdisintegrants
5 Thickeners and Stabilizers
5 Co-Processed Excipients
4 Parenteral
3 Granulation
1 Solubilizers

DIGITAL CONTENT

15 NEWS #PharmaBuzz

15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 6 Finished Drug Prices, 5 Annual Reports

3 US Medicaid Prescriptions
6 Finished Drug Prices
5 Annual Reports

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

39 US Patents, 4 Health Canada Patents

39 US Patents
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 30,418 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 2Merck Canada Inc.

02 2Organon Canada Inc.

filter Patent Reset all filters

4 All

01 22182981

02 22603509

filter Product Reset all filters

4 All

01 4Asenapine

filter Dosage Reset all filters

4 All

01 4tablet

filter Exp Date Reset all filters

4 All

01 22015-03-01

02 22026-04-06

Product Main Page

01

Organon Canada Inc.

Asenapine Maleate

The Generic Rx Session

Not Confirmed

Organon Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-06

Date Granted : 2013-12-03

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2603509

Filing Date : 2006-04-06

Strength per Unit : 5 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2026-04-06

Date Granted : 2013-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Asenapine Maleate

The Generic Rx Session

Not Confirmed

Merck Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-03-01

Date Granted : 2006-10-17

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2182981

Filing Date : 1995-03-01

Strength per Unit : 5 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2015-03-01

Date Granted : 2006-10-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Organon Canada Inc.

Asenapine Maleate

The Generic Rx Session

Not Confirmed

Organon Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-06

Date Granted : 2013-12-03

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2603509

Filing Date : 2006-04-06

Strength per Unit : 10 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2026-04-06

Date Granted : 2013-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Merck Canada Inc.

Asenapine Maleate

The Generic Rx Session

Not Confirmed

Merck Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-03-01

Date Granted : 2006-10-17

Asenapine Maleate

Brand Name : SAPHRIS

Patent Number : 2182981

Filing Date : 1995-03-01

Strength per Unit : 10 mg

Dosage Form : tablet

Human Or VET : Human

Route of Administration : sublingual

Patent Expiration Date : 2015-03-01

Date Granted : 2006-10-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!